000 | 01932 a2200517 4500 | ||
---|---|---|---|
005 | 20250515195318.0 | ||
264 | 0 | _c20100514 | |
008 | 201005s 0 0 eng d | ||
022 | _a1879-0046 | ||
024 | 7 |
_a10.1016/j.drugalcdep.2009.10.014 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aChakrabarti, Amit | |
245 | 0 | 0 |
_aPredictors of buprenorphine-naloxone dosing in a 12-week treatment trial for opioid-dependent youth: secondary analyses from a NIDA Clinical Trials Network study. _h[electronic resource] |
260 |
_bDrug and alcohol dependence _cMar 2010 |
||
300 |
_a253-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aBuprenorphine _xadministration & dosage |
650 | 0 | 4 | _aData Interpretation, Statistical |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNaloxone _xadministration & dosage |
650 | 0 | 4 |
_aNarcotic Antagonists _xtherapeutic use |
650 | 0 | 4 |
_aNarcotics _xtherapeutic use |
650 | 0 | 4 | _aNational Institute on Drug Abuse (U.S.) |
650 | 0 | 4 |
_aOpioid-Related Disorders _xdrug therapy |
650 | 0 | 4 | _aOutpatients |
650 | 0 | 4 |
_aPain _xchemically induced |
650 | 0 | 4 | _aPain Measurement |
650 | 0 | 4 | _aSocioeconomic Factors |
650 | 0 | 4 |
_aSubstance Withdrawal Syndrome _xprevention & control |
650 | 0 | 4 | _aTime Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 | _aUnited States |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aWoody, George E | |
700 | 1 | _aGriffin, Margaret L | |
700 | 1 | _aSubramaniam, Geetha | |
700 | 1 | _aWeiss, Roger D | |
773 | 0 |
_tDrug and alcohol dependence _gvol. 107 _gno. 2-3 _gp. 253-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.drugalcdep.2009.10.014 _zAvailable from publisher's website |
999 |
_c19331961 _d19331961 |